Diabetes mellitus and prognosis in women with breast cancer: A systematic review and meta-analysis

Existing Reviews

Please note, new claims can take a short while to show up.

No claims yet.

Annotation Summary

Term Occurence Count Dictionary
hyperinsulinemia 1 endocrinologydiseases
metformin 3 endocrinologydiseasesdrugs
diabetes mellitus 1 endocrinologydiseases
hyperglycemia 1 endocrinologydiseases

Graph of close proximity drug and disease terms (within 200 characters).

Note: If this graph is empty, then there are no terms that meet the proximity constraint.

Review

Having read the paper, please pick a pair of statements from the paper to indicate that a drug and disease are related.

Select Drug Character Offset Drug Term Instance
metformin 4074 results.[[10]] These conflicting findings may be confounded by diabetes treatments, particularly the use of metformin .[[11]]Here, we conducted a meta-analysis of the available observational studies to investigate the impact
metformin 10444 OS in female breast cancer patients. The study by Hou et al[[25]] provided risk estimate of OS with metformin or without metformin treatment; we therefore pooled the risk estimate, separately. As shown in Fig.
metformin 10465 cancer patients. The study by Hou et al[[25]] provided risk estimate of OS with metformin or without metformin treatment; we therefore pooled the risk estimate, separately. As shown in Fig. 2, a random-effects model
Select Disease Character Offset Disease Term Instance
diabetes mellitus 13153 standard error.Discussion4The present meta-analysis is the first to assess the association between diabetes mellitus and the prognosis of women with breast cancer in terms of DFS and RFP. Our meta-analysis showed that
hyperglycemia 4858 the clinical prognosis of breast cancer patients. The search terms used were (diabetes OR diabetic OR hyperglycemia ) AND (breast cancer OR breast carcinoma OR breast neoplasm) AND (prognosis OR survival OR relapse OR
hyperinsulinemia 16308 breast cancer prognosis is complex. Diabetes can directly influence breast cancer prognosis by altering hyperinsulinemia and insulin-like growth factors, endogenous sex hormones, and inflammatory markers.[[21]] Hyperinsulinemia

You must be authorized to submit a review.